United Therapeutics Corp. (UTHR) PT Lowered to $203 at Ladenburg Thalmann
February 25, 2022 7:01 AM
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $203.00 (from $231.00) while maintaining a Buy rating.
